RGEN Repligen
$163.81 -3.81%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Point at or drag across the chart to read a day. EOD data.
1D
-3.81%
YTD
0.00%
P/E
217.59
P/B
4.38
ROE
-0.6%
Div yield
—
Beta
1.18
Market cap
$10.6B
RSI (14)
43
Next earnings
Feb 22, 2027
Same sector · Health Care
Compare RGEN with NVO and JNJ →Follow RGEN in the AlfaCat app
Watchlist, price and earnings alerts, the chart offline. Free, no account, no ads.
The economy behind it · United States
Economy this week on BullDozer →GDP, % on year
2.1
Q3 2026
Inflation, %
3.7
Sep 2026
Unemployment, %
3.9
Oct 2026
10-yr yield, %
5.13
Oct 2026
From BullDozer, our sister site for country statistics (open sources: OECD, IMF, Eurostat, ILO). Full United States profile →
Previous session
close of Nov 20, 2026 · EOD, no live order bookOpen
$169.61
Close
$163.81
Day high
$169.61
Day low
$162.47
Volume
698K
Latest headlines
Repligen (RGEN) Stock Looks Fairly Valued As Cash Flow Growth Matters
Yahoo Finance · Nov 16
What iShares Russell 2000 Index Fund (IWM) Bought: Jackson Leads on Nov. 5
Yahoo Finance · Nov 9
Repligen: 3 Key Takeaways for Long-Term Investors
Yahoo Finance · Nov 5
Repligen Corporation to Present at Jefferies Global Healthcare Conference
Yahoo Finance · Nov 4
RGEN Q3 deep dive: margin headwinds and BioLife integration shape improved full-year outlook
Yahoo Finance · Nov 1
5 must-read analyst questions from Repligen’s Q3 earnings call
Yahoo Finance · Oct 31
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Nov 6, 2026 View → 10-Q Oct 30, 2026 View → 8-K Oct 30, 2026 View → 8-K Oct 27, 2026 View → 8-K Oct 6, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell RGEN. Try it in the Lab to size a position and see the risk.